Story thread · 3 reports / 2 sources
Emmaus, Cedars-Sinai Extend Pact
labusinessjournal.com · 1d
How the coverage leans
Across 2 sources · syndicated copies counted once
Torrance-based Emmaus Life Sciences Inc. announced Aug. 31 an option agreement with Beverly Grove-based Cedars-Sinai Medical Center to continue researching the use of Emmaus’ existing drug Endari in treating pancreatic cancer. The Food and Drug Administration in 2017 approved the L-glutamine oral powder drug to treat pediatric sickle cell disease. The drug has also been […] The post Emmaus, Cedars-Sinai Extend Pact appeared first on Los Angeles Business Journal .
First report: Dietary supplement glutamine + standard therapy improved outcomes in advanced pancreatic cancer, Cedars-Sinai investigators find — cancerletter.com, 3d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.